Singapore greenlights clinical trials for vaccine candidate developed by Arcturus and Duke-NUS Medical School
July 22, 2020 at 02:16 AM EDT
Biopharmaceutical company Arcturus and Singapore's Duke-NUS said they will begin human dosing tests of their potential coronavirus vaccine as soon as possible.
